# US 2021/0171905 A1 · Method for producing parasympathetic neurons

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0171905 A1
- Document ID: US20210171905A1
- Status: Published application
- Kind: A1
- Application number: 17/268,234
- Filed: 2019-08-23
- Published: 2021-06-10
- Earliest claimed: 2018-08-24
- Assignees: National Institute of Advanced Industrial Science and Technology
- Applicants: National Institute of Advanced Industrial Science and Technology
- Inventors: Yuzo Takayama; Yasuyuki Kida
- Web page: https://patentgrep.com/patent/US20210171905A1

## CPC

- C12N 5/0619: {Neurons}
- C12N 2500/38: Vitamins
- C12N 2501/01: Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
- C12N 2501/115: Basic fibroblast growth factor (bFGF, FGF-2)
- C12N 2501/13: Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
- C12N 2501/155: Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
- C12N 2501/385: of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
- C12N 2501/41: Hedgehog proteins; Cyclopamine (inhibitor)
- C12N 2501/415: Wnt; Frizzeled
- C12N 2501/727: Kinases (EC 2.7.)
- C12N 2501/999: Small molecules not provided for elsewhere
- C12N 2506/02: from embryonic cells
- C12N 2506/08: from cells of the nervous system
- C12N 2506/45: from artificially induced pluripotent stem cells
- C12N 2533/32: Polylysine, polyornithine
- C12N 2533/52: Fibronectin; Laminin
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention provides a method for producing parasympathetic neurons from neural crest cells or autonomic neural progenitor cells derived therefrom, comprising a step of culturing the neural crest cells or autonomic neural progenitor cells derived therefrom in the presence of a cAMP production promoter, a BDNF signaling pathway activator, a GDNF signaling pathway activator, an NGF signaling pathway activator, an NT-3 signaling pathway activator, vitamin C, a protein kinase C activator, and a retinoic acid receptor agonist.

## Claims

### Claim 1

A method for producing parasympathetic neurons from neural crest cells or autonomic neural progenitor cells derived therefrom, the method comprising:
(a) a step of culturing the neural crest cells or autonomic neural progenitor cells derived therefrom in the presence of a cAMP production promoter, a BDNF signaling pathway activator, a GDNF signaling pathway activator, an NGF signaling pathway activator, an NT-3 signaling pathway activator, vitamin C, a protein kinase C activator, and a retinoic acid receptor agonist.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the protein kinase C activator is a phorbol ester or an ingenol ester.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the retinoic acid receptor agonist is retinoic acid, tamibarotene, or Ch55.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the protein kinase C activator is phorbol 12-myristate 13-acetate, and the retinoic acid receptor agonist is all-transretinoic acid.

### Claim 5 (depends on 1)

The method according to claim 1, the method further comprising
(b) a step of culturing the neural crest cells or autonomic neural progenitor cells derived therefrom in the presence of a BMP signaling pathway activator, an SHH signaling pathway inhibitor, and a Wnt signaling pathway inhibitor, before the step (a).

### Claim 6 (depends on 5)

The method according to claim 5, wherein the BMP signaling pathway activator is BMP2, BMP4, BMP7, or BMP2/4, the SHH signaling pathway inhibitor is SANT-1, SANT-2, JK184, or jervine, and the Wnt signaling pathway inhibitor is IWR-1, XAV939, or IWP-2.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the neural crest cells or autonomic neural progenitor cells derived therefrom are seeded at a concentration of 2×105 to 5×105 cells/cm2.

### Claim 8 (depends on 1)

The method according to claim 1, wherein the neural crest cells or autonomic neural progenitor cells derived therefrom are derived from a human.

### Claim 9 (depends on 1)

The method according to claim 1, wherein the neural crest cells or autonomic neural progenitor cells derived therefrom are differentiation-induced from pluripotent stem cells.

### Claim at position 10

-11. (canceled)

### Claim 12

A kit for producing parasympathetic neurons from neural crest cells or autonomic neural progenitor cells derived therefrom, the kit comprising a cAMP production promoter, a BDNF signaling pathway activator, a GDNF signaling pathway activator, an NGF signaling pathway activator, an NT-3 signaling pathway activator, vitamin C, a protein kinase C activator, and a retinoic acid receptor agonist.
